The pharmacological advantage of prolonged dose rate gemcitabine is restricted to patients with variant alleles of cytidine deaminase c.79A>C
- Ekkaphon Metharom
- , Peter Galettis
- , Susan Manners
- , Maria Jelinek
- , Winston Liauw
- , Paul L De Souza
- , Janelle M Hoskins
- , M. Links*
*Corresponding author for this work
Research output: Contribution to journal › Article › Research › peer-review
9
Link opens in a new tab
Citations
(Scopus)